Literature DB >> 23061591

When does an illness begin: genetic discrimination and disease manifestation.

Anya E R Prince1, Benjamin E Berkman.   

Abstract

The Genetic Information Nondiscrimination Act of 2008 (GINA) was passed to encourage patients to seek genetic testing that could improve health outcomes and provide opportunities for preventive measures. GINA protects individuals from discrimination based upon genetic information, but not upon manifested diseases and conditions. Because the manifestation of a disease establishes a threshold of protection for individuals under GINA, the definition of manifestation is crucial to understanding the scope of the bill. This paper examines the range of possible legal definitions of disease manifestation and explores the historical struggle that courts have faced when trying to apply these different definitions. Specifically, the paper examines three frameworks that courts have used in the past to interpret the manifestation of a disease; "manifestation as apparent symptoms,""manifestation as patient action," and "manifestation as physician action." We argue that the "manifestation as physician action" is the best framework to utilize in this law generally, but that the definition of manifestation should be read in the light most favorable to a plaintiff in order to achieve the underlying goals of GINA.
© 2012 American Society of Law, Medicine & Ethics, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23061591      PMCID: PMC4142506          DOI: 10.1111/j.1748-720X.2012.00696.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  3 in total

1.  Currents in contemporary ethics. GINA, the ADA, and genetic discrimination in employment.

Authors:  Mark A Rothstein
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

2.  Charting a course for genomic medicine from base pairs to bedside.

Authors:  Eric D Green; Mark S Guyer
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

3.  GINA, genism, and civil rights.

Authors:  George J Annas; Patricia Roche; Robert C Green
Journal:  Bioethics       Date:  2008-08       Impact factor: 1.898

  3 in total
  4 in total

Review 1.  Confidentiality & the Risk of Genetic Discrimination: What Surgeons Need to Know.

Authors:  Amanda Gammon; Deborah W Neklason
Journal:  Surg Oncol Clin N Am       Date:  2015-07-16       Impact factor: 3.495

Review 2.  Immunoaffinity Capillary Electrophoresis in the Era of Proteoforms, Liquid Biopsy and Preventive Medicine: A Potential Impact in the Diagnosis and Monitoring of Disease Progression.

Authors:  Norberto A Guzman; Daniel E Guzman
Journal:  Biomolecules       Date:  2021-10-01

3.  Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.

Authors:  Michael Benatar; Joanne Wuu; Caroline McHutchison; Ronald B Postuma; Bradley F Boeve; Ronald Petersen; Christopher A Ross; Howard Rosen; Jalayne J Arias; Stephanie Fradette; Michael P McDermott; Jeremy Shefner; Christine Stanislaw; Sharon Abrahams; Stephanie Cosentino; Peter M Andersen; Richard S Finkel; Volkan Granit; Anne-Laure Grignon; Jonathan D Rohrer; Corey T McMillan; Murray Grossman; Ammar Al-Chalabi; Martin R Turner
Journal:  Brain       Date:  2022-03-29       Impact factor: 15.255

Review 4.  Genomic knowledge sharing: A review of the ethical and legal issues.

Authors:  Leslie P Francis
Journal:  Appl Transl Genom       Date:  2014-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.